{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T04:47:11Z","timestamp":1782103631578,"version":"3.54.5"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Fund Project of Shanghai Jiading District Health Commission","award":["2021-KY-ZYY-07"],"award-info":[{"award-number":["2021-KY-ZYY-07"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Histol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s10735-026-10822-2","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T02:32:20Z","timestamp":1779244340000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical efficacy of Fufang Zaofan Pills and their immunomodulatory effects on peripheral blood dendritic cells in individuals with lower-risk myelodysplastic syndrome"],"prefix":"10.1007","volume":"57","author":[{"given":"Fei-Fei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yun","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Lai","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-Wen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Zhen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Jun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-Hua","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"issue":"6","key":"10822_CR1","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1007\/s11864-024-01217-0","volume":"25","author":"MR Battaglia","year":"2024","unstructured":"Battaglia MR, Cannova J, Madero-Marroquin R, Patel AA (2024) Treatment of anemia in lower-risk myelodysplastic syndrome. Curr Treat Options Oncol 25(6):752\u2013768. https:\/\/doi.org\/10.1007\/s11864-024-01217-0","journal-title":"Curr Treat Options Oncol"},{"issue":"11","key":"10822_CR2","doi-asserted-by":"publisher","first-page":"4595","DOI":"10.1172\/JCI67580","volume":"123","author":"X Chen","year":"2013","unstructured":"Chen X, Eksioglu EA, Zhou J, Zhang L, Djeu J, Fortenbery N, Epling-Burnette P, Van Bijnen S, Dolstra H, Cannon J, Youn JI, Donatelli SS, Qin D, De Witte T, Tao J, Wang H, Cheng P, Gabrilovich DI, List A, Wei S (2013) Induction of myelodysplasia by myeloid-derived suppressor cells. J Clin Invest 123(11):4595\u20134611. https:\/\/doi.org\/10.1172\/JCI67580","journal-title":"J Clin Invest"},{"issue":"2","key":"10822_CR3","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3760\/cma.j.issn.0253-2727.2019.02.001","volume":"40","author":"Chinese Society of Hematology","year":"2019","unstructured":"Chinese Society of Hematology, Chinese Medical Association (2019) [Chinese guidelines for diagnosis and treatment of myelodysplastic syndromes (2019)]. Zhonghua Xue Ye Xue Za Zhi 40(2):89\u201397. https:\/\/doi.org\/10.3760\/cma.j.issn.0253-2727.2019.02.001","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"issue":"12","key":"10822_CR4","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","volume":"120","author":"PL Greenberg","year":"2012","unstructured":"Greenberg PL, Tuechler H, Schanz J, Sanz G, Garcia-Manero G, Sol\u00e9 F, Bennett JM, Bowen D, Fenaux P, Dreyfus F, Kantarjian H, Kuendgen A, Levis A, Malcovati L, Cazzola M, Cermak J, Fonatsch C, Le Beau MM, Slovak ML, Krieger O, Luebbert M, Maciejewski J, Magalhaes SM, Miyazaki Y, Pfeilst\u00f6cker M, Sekeres M, Sperr WR, Stauder R, Tauro S, Valent P, Vallespi T, van de Loosdrecht AA, Germing U, Haase D (2012) Revised international prognostic scoring system for myelodysplastic syndromes. Blood 120(12):2454\u20132465. https:\/\/doi.org\/10.1182\/blood-2012-03-420489","journal-title":"Blood"},{"issue":"8","key":"10822_CR5","doi-asserted-by":"publisher","first-page":"914","DOI":"10.7661\/j.cjim.20180702.187","volume":"38","author":"XM Hu","year":"2018","unstructured":"Hu XM, Zhou YM (2018) Myelodysplastic syndromes: expert consensus on integrated traditional Chinese and western medicine diagnosis and treatment (2018). Chin J Integr Med 38(8):914\u2013920. https:\/\/doi.org\/10.7661\/j.cjim.20180702.187","journal-title":"Chin J Integr Med"},{"key":"10822_CR6","unstructured":"National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0[EB\/OL]. 2017."},{"issue":"4","key":"10822_CR7","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.3390\/curroncol31040148","volume":"31","author":"D Karel","year":"2024","unstructured":"Karel D, Valburg C, Woddor N, Nava VE, Aggarwal A (2024) Myelodysplastic neoplasms (MDS): the current and future treatment landscape. Curr Oncol 31(4):1971\u20131993. https:\/\/doi.org\/10.3390\/curroncol31040148","journal-title":"Curr Oncol"},{"issue":"9","key":"10822_CR8","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1182\/blood-2016-03-703702","volume":"128","author":"S Kordasti","year":"2016","unstructured":"Kordasti S, Costantini B, Seidl T, Perez Abellan P, Martinez Llordella M, McLornan D, Diggins KE, Kulasekararaj A, Benfatto C, Feng X, Smith A, Mian SA, Melchiotti R, de Rinaldis E, Ellis R, Petrov N, Povoleri GA, Chung SS, Thomas NS, Farzaneh F, Irish JM, Heck S, Young NS, Marsh JC, Mufti GJ (2016) Deep phenotyping of Tregs identifies an immune signature for idiopathic aplastic anemia and predicts response to treatment. Blood 128(9):1193\u20131205. https:\/\/doi.org\/10.1182\/blood-2016-03-703702","journal-title":"Blood"},{"issue":"2","key":"10822_CR9","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3969\/j.issn.1671-4695.2023.02.015","volume":"22","author":"SF Liu","year":"2023","unstructured":"Liu SF, Li LN, Yang G (2023) Clinical efficacy of decitabine combined with compound Zaofan pills on myelodysplastic syndrome and its effect on inflammation and quality of life. Clin Exp Med 22(2):161\u2013164. https:\/\/doi.org\/10.3969\/j.issn.1671-4695.2023.02.015","journal-title":"Clin Exp Med"},{"issue":"4","key":"10822_CR10","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.cll.2023.06.002","volume":"43","author":"H Mendoza","year":"2023","unstructured":"Mendoza H, Siddon AJ (2023) Molecular techniques and gene mutations in myelodysplastic syndromes. Clin Lab Med 43(4):549\u2013563. https:\/\/doi.org\/10.1016\/j.cll.2023.06.002","journal-title":"Clin Lab Med"},{"key":"10822_CR11","unstructured":"National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology: Myelodysplastic Syndromes (Version 1.2018)[EB\/OL]. (2018\u201301\u201301)[2023\u201312\u201301].\u00a0https:\/\/www.nccn.org."},{"key":"10822_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.994053","volume":"13","author":"X Peng","year":"2022","unstructured":"Peng X, Zhu X, Di T, Tang F, Guo X, Liu Y, Bai J, Li Y, Li L, Zhang L (2022) The yin-yang of immunity: immune dysregulation in myelodysplastic syndrome with different risk stratification. Front Immunol 13:994053. https:\/\/doi.org\/10.3389\/fimmu.2022.994053","journal-title":"Front Immunol"},{"issue":"14","key":"10822_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14143545","volume":"14","author":"X Roussel","year":"2022","unstructured":"Roussel X, Garnache Ottou F, Renosi F (2022) Plasmacytoid dendritic cells, a novel target in myeloid neoplasms. Cancers (Basel) 14(14):3545. https:\/\/doi.org\/10.3390\/cancers14143545","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10822_CR14","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1001\/jama.2022.14578","volume":"328","author":"MA Sekeres","year":"2022","unstructured":"Sekeres MA, Taylor J (2022) Diagnosis and treatment of myelodysplastic syndromes: a review. JAMA 328(9):872\u2013880. https:\/\/doi.org\/10.1001\/jama.2022.14578","journal-title":"JAMA"},{"issue":"40","key":"10822_CR15","doi-asserted-by":"publisher","first-page":"53577","DOI":"10.1021\/acsami.4c12821","volume":"16","author":"P Srivastava","year":"2024","unstructured":"Srivastava P, R\u00fctter M, Antoniraj GM, Ventura Y, David A (2024) Dendritic cell-targeted nanoparticles enhance T cell activation and antitumor immune responses by boosting antigen presentation and blocking PD-L1 pathways. ACS Appl Mater Interfaces 16(40):53577\u201353590. https:\/\/doi.org\/10.1021\/acsami.4c12821","journal-title":"ACS Appl Mater Interfaces"},{"issue":"6","key":"10822_CR16","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","volume":"140","author":"O Takeuchi","year":"2010","unstructured":"Takeuchi O, Akira S (2010) Pattern recognition receptors and inflammation. Cell 140(6):805\u2013820. https:\/\/doi.org\/10.1016\/j.cell.2010.01.022","journal-title":"Cell"},{"issue":"3","key":"10822_CR17","doi-asserted-by":"publisher","first-page":"655","DOI":"10.3324\/haematol.2020.268136","volume":"107","author":"N Van Leeuwen-Kerkhoff","year":"2022","unstructured":"Van Leeuwen-Kerkhoff N, Westers TM, Poddighe PJ, Povoleri GAM, Timms JA, Kordasti S, De Gruijl TD, Van de Loosdrecht AA (2022) Reduced frequencies and functional impairment of dendritic cell subsets and non-classical monocytes in myelodysplastic syndromes. Haematologica 107(3):655\u2013667. https:\/\/doi.org\/10.3324\/haematol.2020.268136","journal-title":"Haematologica"},{"issue":"3","key":"10822_CR18","first-page":"249","volume":"42","author":"HQ Wang","year":"2021","unstructured":"Wang HQ, Shao ZH (2021) Research advances in dendritic cell dysfunction in patients with myelodysplastic syndromes. Chin J Hematol 42(3):249\u2013253","journal-title":"Chin J Hematol"},{"key":"10822_CR19","doi-asserted-by":"publisher","first-page":"115","DOI":"10.4103\/wjtcm.wjtcm_44_21","volume":"8","author":"LM Xia","year":"2022","unstructured":"Xia LM, Zhang AP, Zheng Q, Ding J, Jin Z, Yu H, Wong WH, Yu HP (2022) Quercetin-3-O-\u03b2-D-glucuronide inhibits mitochondria pathway-mediated platelet apoptosis via the phosphatidylinositol-3-kinase\/AKT pathway in immunological bone marrow failure. World J Tradit Chin Med 8:115\u2013122. https:\/\/doi.org\/10.4103\/wjtcm.wjtcm_44_21","journal-title":"World J Tradit Chin Med"},{"key":"10822_CR20","first-page":"387","volume":"6","author":"Y Xiao","year":"2004","unstructured":"Xiao Y, Li SW, Ren WW, Zhang H (2004) Effect of Compound Zaofan pills on the hemopoietic function in mice with radiation injury. New Traditi Chin Med Clin Pharmacol 6:387\u2013389","journal-title":"New Traditi Chin Med Clin Pharmacol"},{"issue":"39","key":"10822_CR21","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1146\/annurev-immunol-101819-025146","volume":"26","author":"X Yin","year":"2021","unstructured":"Yin X, Chen S, Eisenbarth SC (2021) Dendritic cell regulation of T helper cells. Annu Rev Immunol 26(39):759\u2013790. https:\/\/doi.org\/10.1146\/annurev-immunol-101819-025146","journal-title":"Annu Rev Immunol"},{"issue":"12","key":"10822_CR22","first-page":"2004","volume":"31","author":"Y Yu","year":"2016","unstructured":"Yu Y, Wang W (2016) Clinical study on Compound Zaofan Pills combined with cyclosporine A and thalidomide in treatment of low-risk myelodysplastic syndromes. Drugs Clinic 31(12):2004\u20132008","journal-title":"Drugs Clinic"},{"key":"10822_CR23","first-page":"152","volume-title":"Diagnosis and efficacy standards of hematologic diseases","author":"ZN Zhang","year":"2018","unstructured":"Zhang ZN, Shen T (2018) Diagnosis and efficacy standards of hematologic diseases, 4th ed. Science Press, Beijing, pp 152\u2013160","edition":"4th ed"},{"issue":"10","key":"10822_CR24","first-page":"873","volume":"41","author":"ZC Zhang","year":"2018","unstructured":"Zhang ZC, Zhang XB, Ding H, Jia MR, Wang C, Chen XY, Tian SD (2018) Meta-analysis of the efficacy and safety of compound Zaofan Pills alone or combined with Western medicine in the treatment of blood diseases. J Beijing Univ Tradit Chin Med 41(10):873\u2013880","journal-title":"J Beijing Univ Tradit Chin Med"}],"container-title":["Journal of Molecular Histology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-026-10822-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10735-026-10822-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-026-10822-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T03:48:46Z","timestamp":1782100126000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10735-026-10822-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10822"],"URL":"https:\/\/doi.org\/10.1007\/s10735-026-10822-2","relation":{},"ISSN":["1567-2379","1567-2387"],"issn-type":[{"value":"1567-2379","type":"print"},{"value":"1567-2387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"assertion":[{"value":"19 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was conducted with approval from the Ethics Committee of Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences (Approval No. 2022K03). This study was conducted in accordance with the declaration of Helsinki. Written informed consent was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"170"}}